1.
Borsi E, Martello M, Santacroce B, Zamagni E, Tacchetti P, Pantani L, Mancuso K, Rocchi S, Cavo M, Terragna C. Treatment optimization for multiple myeloma: schedule-dependent synergistic cytotoxicity of pomalidomide and carfilzomib in in vitro and ex vivo models. Haematologica 2018; 103(12):e602-e606; https://doi.org/10.3324/haematol.2017.186924.